Description
Recombinant Human A2AR Protein-VLP
|
Name
|
Catalog No.
|
Size
|
|
Recombinant Human A2AR Protein-VLP
|
C230757E
|
20 μg
|
|
C230757S
|
100 μg
|
|
C230757M
|
100 μg
|
|
C230757L
|
1 mg
|
Product Properties
|
Synonyms
|
A2AR / AA2AR / ADORA2A / ADORA2
|
|
Source
|
HEK293 Cells
|
|
AA sequence
|
Accession #P29274: Met1 - Ser412
|
|
Endotoxin
|
< 1EU per μg by the LAL method.
|
|
Purity
|
>95% as determined by DLS.
|
|
Formulation
|
115mM Gly 4% trehalose
|
|
Activity
|
ELISA：Immobilized Human A2AR VLP at 5 ug/mL (30 uL/well) can bind 3F6-9G5(P57584) , The EC50 was approximately 0.02377 µg/ml.
|
|
Applications
|
ELISA, Kinetics (BLI), Kinetics (SPR), Immunization
|
|
Dilution
|
Dilute with PBS.
|
Figure
Figure 1. The mean peak Radius of VLP is 117.7 nm with more than 95% intensity as determined by dynamic light scattering (A). Immobilized Human A2AR VLP at 5 ug/mL (30 uL/well) can bind 3F6-9G5(P57584) , The EC50 was approximately 0.02377 µg/ml (B).
Storage
The product should be stored at -85~-65℃ for 1 year from date of receipt.
Recommend to aliquot the protein into smaller quantities when first used and avoid repeated freeze-thaw cycles.
Cautions
1. Please operate with lab coats and disposable gloves,for your safety.
2. This product is for research use only.
